Development of Targeted Adjuvants for HIV-1 Vaccines

AIDS Research and Therapy - United Kingdom
doi 10.1186/s12981-017-0165-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Advances in Antibody-Based HIV-1 Vaccines Development

Vaccines
Drug DiscoveryInfectious DiseasesImmunologyPharmacology
2020English

Promising Plant-Derived Adjuvants in the Development of Coccidial Vaccines

Frontiers in Veterinary Science
Veterinary
2019English

Recent Advances in the Development of HIV-1 Vaccines Using Replication-Incompetent Adenovirus Vectors

Annual Review of Medicine
BiochemistryMedicineGeneticsMolecular Biology
2004English

New Developments in Oral Vaccines and Mucosal Adjuvants

Recent Patents on Inflammation and Allergy Drug Discovery
MedicineDrug DiscoveryAllergyImmunology
2015English

Mucosal Adjuvants for Vaccines to Control Upper Respiratory Infections in the Elderly

Experimental Gerontology
AgingGeneticsCell BiologyMolecular BiologyBiochemistryEndocrinology
2014English

Aluminum Oxide Nanowires as Safe and Effective Adjuvants for Next-Generation Vaccines

Materials Today
Mechanics of MaterialsMaterials ScienceCondensed Matter PhysicsMechanical Engineering
2019English

Design Opportunities for Actively Targeted Nanoparticle Vaccines

Nanomedicine
DevelopmentMaterials ScienceNanoscienceMedicineBioengineeringNanotechnologyBiomedical Engineering
2008English

OA021-03. Design and Development of DNA Vaccines for the Co-Expression of Micro-Rna and HIV-1 Env

Retrovirology
VirologyInfectious Diseases
2009English

New Approaches to Design HIV-1 T-Cell Vaccines

Current Opinion in HIV and AIDS
VirologyOncologyInfectious DiseasesImmunologyHematology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy